Supplementary Fig. 7 . Differential perturbation of the HDX-MS profile of SIRT1 upon binding to STAC 1 in the absence or presence of Ac-p53(W5) (Trp-5mer). The perturbed sequence is mapped on the Mini-hSIRT1/1 complex structure (gray). The green-highlighted region is pertubated on SIRT1 WT or E230K mutant upon binding to STAC 1 in the absence or presence of Ac-p53(W5) (Trp-5mer). The red-highlighted region is only pertubated on SIRT1 WT upon binding to STAC 1 in the presence of Ac-p53(W5) (Trp-5mer). Maximum activation values (RV max ) determined from activation dose-response curves using Eq. 1. Activation was measured using the OAcADPr assay assay with Ac-p53(W5) substrate. No maximum activation values for I223R were shown because no activation was observed. 
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SI Materials and Methods
Preparation of Compounds 1-9:
General Methods. Reagents were obtained from commercial sources and were used as received. All reactions were run under an inert atmosphere (N 2 ). Flash column chromatography was performed on silica gel, particle size 60 Å, mesh of 230−400 (Merck) under standard techniques. Unless otherwise indicated, chromatography refers to medium pressure chromatography performed on an ISCO Combiflash Rf or similar system. Purities of all compounds were determined by analytical HPLC using the area percentage method on the UV trace recorded at a wavelength of 254 nm, and compounds were found to have ≥ 95% purity unless otherwise specified. Analytical HPLC was performed on an Agilent 1100 Series HPLC equipped with a 3.5 μm Eclipse XDB-C18 (4.6 mm  100 mm) column with the following conditions: CH 3 CN/H 2 O, modified with 0.1% formic acid mobile phase. Gradient elution: 5% CH 3 CN hold (2 min), 5% to 95% CH 3 CN gradient (11 min), 95% to 5% CH 3 CN gradient (0.3 min), 5% CH 3 CN hold (2.7 min), 15 min total run time with a flow rate of 0.8 ml/min. 1 H NMR spectra were obtained on a Bruker Advance III 300 MHz spectrometer and referenced to internal TMS (0.00 ppm), CHCl 3 (7.26 ppm), or DMSO (2.49 ppm). NMR spectral data are reported as follows: chemical shift (δ) in ppm, (multiplicity, coupling constants in Hertz, number of protons, assignment). Multiplicity abbreviations are as follows: s-singlet, d-doublet, t-triplet, q-quartet, m-multiplet, br-broad. Low Resolution Mass Spectral (LRMS) data were recorded using an Agilent 1100 series spectrometer integrated into an Agilent 1200 series HPLC system, in electrospray positive mode ionization. High Resolution Mass Spec (HRMS) was completed on a Waters qTOF Premiere Mass Spectrometer operating in W mode positive ionization with a resolving power of approximately 15,000. Flow injection was completed using a Waters nano-acquity LC. HRMS acceptable error is 3 mDa or 5 ppm, although most analyses are observed within 0.5 mDa with isotope fits in good agreement with the proposed structures.
Scheme S1, Preparation of Compound 1:
Reagents and conditions: a) NaHCO 3 , THF, 40 °C; b) Fe, AcOH, IPA/Water 70°C, c) LAH, THF, 0-5 °C; d) POCl 3 , CH 2 Cl 2 , TEA, e) 3-trifluorophenylboronic acid, Pd(OAc) 2 , XPhos, Cs 2 CO 3 , Dioxane/Water; f) triphosgene, TEA, CH 2 Cl 2 , reflux.
(S)-Dimethyl 2-((6-chloro-3-nitropyridin-2-yl)amino)succinate (13). To a 2 L flask equipped with a thermometer, a reflux condenser, and a mechanical stirrer was added 2,6-dichloro-3-nitropyridine (11; 100 g, 0.52 mol), (S)-aspartic acid dimethyl ester hydrochloride (12; 205 g, 1.04 mol), NaHCO 3 (174 g, 2.07 mol) and tetrahydrofuran (1 L). The reaction was stirred at 40 °C for 16 h, and was monitored for the disappearance of 2,6-dichloropyridine by HPLC. After the reaction was complete, the solids were filtered away and washed with ethyl acetate (3  300 mL). The combined filtrate and washings were concentrated to dryness, and the residue was taken up in 1 L of ethyl acetate. The solution was stirred with charcoal (200 g) at ambient temperature for 2 h, and the charcoal was filtered away and washed with additional ethyl acetate (3 x 200 mL). The combined filtrate and washings were concentrated in vacuo to obtain crude (S)-dimethyl 2-((6-chloro-3-nitropyridin-2-yl)amino)succinate (13; 180 g, >100%) as a yellow oil. This was used in the next step without further purification. LRMS (m/z): 318. Methyl 2-(6-chloro-2-oxo-1,2,3,4-tetrahydropyrido[2,3-b]pyrazin-3-yl)acetate (14) . To a 5L three necked flask equipped with a thermometer, a reflux condenser, and a mechanical stirrer was charged with crude (S)-dimethyl 2-((6-chloro-3-nitropyridin-2-yl)amino)succinate (13; 180 g, 0.52 mol), iron powder (146 g, 2.59 mol), 2-propanol (2 L) and water (700 mL). The mixture was stirred at 40 °C, then acetic acid (15.5 g, 0.259 mmol) was added at a rate sufficient to keep the internal temperature below 70 °C. The reaction was stirred at 70 °C for 30 min, HPLC indicated that the reaction was complete. The mixture was cooled to 40 °C, then Na 2 CO 3 (165 g, 1.55 mol) was added, and the mixture was stirred for 1 h. The solids were filtered, and the solids were washed with tetrahydrofuran (3 x 500 mL). The combined filtrate and washings were concentrated in vacuo, then the residue was stirred in ethanol (1 L) for 12 hrs. The solid was filtered and washed with cold ethanol, and dried in vacuo to obtain (S)-methyl 2-(6-chloro-2-oxo-1,2,3,4-tetrahydropyrido [ Chloro-1,2,3,4-tetrahydropyrido[2,3-b]pyrazin-3-yl)ethanol (15) . A 5L 3-necked flask equipped with a mechanical stirrer, a reflux condenser, and a nitrogen inlet was charged with LiAlH 4 (60 g, 1.58 mol). The flask was cooled with an ice bath, and tetrahydrofuran (500 mL) was added. The stirred mixture was cooled to 0 °C, then a solution of (S)-methyl 2-(6-chloro-2-oxo-1,2,3,4-tetrahydropyrido[2,3-b]pyrazin-3-yl)acetate (14; 81 g, 0.32 mol) in tetrahydrofuran (2 L) was added, while keeping the internal temperature below 5 °C. After the addition was complete, the reaction was heated at reflux for 16 h, while monitoring for the appearance of product by HPLC. The ester reduction occurred rapidly, while the lactam reduction required longer for complete reduction. The reaction was cooled to 5 °C, then water (60 mL) was added while keeping the internal temperature below 10 °C. After addition was complete, the reaction was stirred for 15 min. Then 15% (w/w) NaOH (aq.) (60 mL) was added while keeping the internal temperature below 5 °C. After addition was complete, the reaction was stirred for 15 min, then water (180 mL) was added and the mixture was stirred at ambient temperature for 1 h. The solids were filtered off and washed with tetrahydrofuran (3 x 150 mL). The filtrate and washings were concentrated in vacuo, then the solid residue was dried in vacuo to obtain (S)-2-(6-chloro-1,2,3 [2,3-b] pyrazin-3-yl)ethanol (15; 50 g, 0.234 mol) in CH 2 Cl 2 (500 mL) was added triethylamine (95 g, 0.936 mol). The mixture was stirred at ambient temperature until it was homogeneous, and then cooled to 0 °C. To the reaction mixture was added dropwise POCl 3 (54 g, 0.351 mol) while maintaining the temperature between 0 -5 °C. Cooling was removed and the reaction was stirred at ambient temperature for 2 h, while monitoring for the disappearance of the starting alcohol by HPLC. After the reaction was complete, 1.2M NaHCO 3(aq.) (200 mL) was added. The layers were separated and the aqueous layer was extracted with CH 2 Cl 2 . The combined CH 2 Cl 2 layers were extracted with 1M HCl (aq.) (4 x 300 mL), and the combined HCl layers were adjusted to pH 8 with solid NaHCO 3 . The resulting mixture was extracted with CH 2 Cl 2 (4 x 300 mL), and this set of CH 2 Cl 2 layers were dried (Na 2 SO 4 ), filtered, and treated with charcoal (50 g). The mixture was stirred at ambient temperature for 3 h, filtered, and the charcoal was washed with CH 2 Cl 2 ( 200 mL). The combined filtrate and wash solution were concentrated to dryness, and the solid residue was dried in vacuo to obtain (4S) Trifluoromethyl)phenyl)-2,3,4,5-tetrahydro-1,4-methanopyrido[2,3-b][1,4 ]diazepine (17). To a solution of (4S)-7-chloro-2,3,4,5-tetrahydro-1,4-methanopyrido [2,3-b] [1, 4] diazepine (16; 5.0 g, 25.6 mmol), 3-trifluoromethylphenylboronic acid (7.3 g, 38 mmol), Pd(OAc) 2 (0.14 g, 0.63 mmol), 2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl (0.61 g, 1.3 mmol) and Cs 2 CO 3 (24.9 g, 76.4 mmol) in a mixture of dioxane (100 mL) and water (10 mL) was heated at reflux for 2.5 hr and cooled to room temperature. The reaction mixture was filtered through celite and concentrated. The residue was diluted with ethyl acetate and the organic layer was washed with aqueous sat. NaHCO 3 , water, brine, dried (Na 2 SO 4 ) and concentrated to dryness. Purification by silica gel chromatography (50-100% ethyl acetate gradient in pentane) afforded (4S) 
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(4S)-7-Chloro-2,3,4,5-tetrahydro-1,4-methanopyrido[2,3-b][1,4]diazepine (16). To a solution of (S)-2-(6-chloro-1,2,3,4-tetrahydropyrido
-
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Preparation of Compound 2:
The preparation procedure of Compound 2 has been reported previously 1 After stirring for 2.5 hr at room temperature, 2-methylquinoxalin-5-amine (52 mg, 0.327 mmol) was added. The reaction mixture was heated at reflux for 2 hours and cooled to room temperature. Saturated aqueous NaHCO 3 was added and the reaction mixture was extracted with CH 2 Cl 2 (3x), and the combined organics were washed with brine, dried (Na 2 SO 4 ) and concentrated. Purification by silica gel chromatography (20 to 100 % ethyl acetate in pentane gradient) afforded impure desired product (8; 80.6 mg, 83% purity). The impure material (8; 80 mg, 83% purity) was recrystallized from ethanol, dried under high vacuum to afford (4S)-N-(2-methylquinoxalin-5-yl)-7-(3-(trifluoromethyl)phenyl)-3,4-dihydro-1,4-methanopyrido [2,3- 
